| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. (NCT05363072) | Pfizer | 2022-05-02 |
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT05119335) | NiKang Therapeutics, Inc. | 2021-10-26 |
| Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients (NCT05068180) | RenJi Hospital | 2021-10-05 |
| Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries (NCT04669366) | Pfizer | 2021-01-20 |
| A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India (NCT04513522) | Bristol-Myers Squibb | 2020-12-17 |
| Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach (NCT05218811) | Urological Research Network, LLC | 2020-05-15 |
| LPN in Patients With High-complex Renal Tumors (NCT04933604) | Samsun Liv Hospital | 2019-09-01 |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. (NCT03943771) | University Hospital, Bordeaux | 2019-07-01 |
| Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study (NCT05729763) | San Luigi Gonzaga Hospital | 2019-06-01 |
| 3D Virtual Models as an Adjunct to Preoperative Surgical Planning (NCT03606044) | Dr Eoin R Hyde | 2019-05-01 |
| Laparoscopic Partial Nephrectomy for cT1 Tumors (NCT04213157) | Samsun Liv Hospital | 2019-03-15 |
| MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers (NCT06126159) | Chang Gung Memorial Hospital | 2019-02-11 |
| The Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtration Rate in Patients With Small Renal Mass: a Single-center, Single-blinded, Randomized, Parallel Group Clinical Trial (NCT02841020) | University of Virginia | 2018-06-01 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
| Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma (NCT03062410) | Centre Hospitalier Universitaire de Besancon | 2017-05-04 |
| Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib (NCT03129724) | University Hospital, Strasbourg, France | 2016-09-01 |
| A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma (NCT02837991) | Celldex Therapeutics | 2016-06-01 |
| Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage (NCT02734329) | RenJi Hospital | 2016-04-01 |
| The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer (NCT02404584) | Centre Hospitalier Universitaire de Nīmes | 2015-12-29 |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer (NCT02543645) | Celldex Therapeutics | 2015-10-01 |
| Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response (NCT02439008) | Centre Oscar Lambret | 2015-09-16 |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma (NCT02386111) | Celldex Therapeutics | 2015-05-01 |
| IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) (NCT02228954) | Radboud University Medical Center | 2014-12-01 |
| Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT (NCT02371551) | Insel Gruppe AG, University Hospital Bern | 2014-08-19 |
| Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors (NCT02077933) | Novartis Pharmaceuticals | 2014-05-14 |
| Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy (NCT01892059) | The First Affiliated Hospital with Nanjing Medical University | 2013-05-01 |
| Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy (NCT01809119) | University of Sao Paulo | 2012-12-01 |
| Imaging Studies of Kidney Cancer Using 18F-VM4-037 (NCT01712685) | National Cancer Institute (NCI) | 2012-10-01 |
| Cabozantinib for Advanced Urothelial Cancer (NCT01688999) | National Cancer Institute (NCI) | 2012-09-11 |
| [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment (NCT01633255) | National Cancer Institute (NCI) | 2012-04-18 |
| A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy (NCT01218854) | National Institutes of Health Clinical Center (CC) | 2012-03-20 |
| The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy (NCT01413607) | Ricardo Rendon | 2011-09-01 |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma (NCT01339975) | University Hospital, Bordeaux | 2011-06-06 |
| Tracking Renal Tumors After Cryoablation Evaluation (NCT01117779) | Boston Scientific Corporation | 2010-07-09 |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties (NCT00980317) | Tokushukai Medical Group | 2009-07-01 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer (NCT00816686) | Astellas Pharma Inc | 2008-10-01 |
| Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer (NCT00678392) | Pfizer | 2008-09-03 |
| Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) (NCT00651482) | Sandy Srinivas | 2008-08-01 |
| Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI (NCT00537056) | Stanford University | 2007-10-01 |
| A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer (NCT00375674) | Pfizer | 2007-08-01 |
| Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer (NCT00491621) | Centre Hospitalier Universitaire de Saint Etienne | 2007-04-01 |
| CT Versus CEUS Findings of Complex Cystic Renal Lesions (NCT01159717) | University Hospital, Basel, Switzerland | 2007-01-01 |
| Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer (NCT00282048) | Pfizer | 2006-03-01 |
| Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions (NCT03160274) | The University of Texas Health Science Center at San Antonio | 2005-10-19 |
| Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors (NCT00221728) | University Hospital, Bordeaux | 2005-04-01 |
| Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors (NCT00507884) | M.D. Anderson Cancer Center | 2005-03-01 |
| Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium (NCT00101608) | Bristol-Myers Squibb | 2005-01-01 |
| Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer (NCT00091611) | National Cancer Institute (NCI) | 2004-09-01 |
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer (NCT00095108) | ZymoGenetics | 2004-05-01 |
| Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma (NCT00076011) | Pfizer | 2003-10-01 |
| Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) (NCT00065572) | AstraZeneca | 2003-08-01 |
| Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma (NCT00065468) | Pfizer | 2003-07-01 |
| The Association of Marital Status With Kidney Cancer Surgery Morbidity (NCT05526599) | Beijing Tsinghua Chang Gung Hospital | 2003-01-01 |
| Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer (NCT00054886) | Pfizer | 2003-01-01 |
| A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma (NCT00226980) | Stanford University | 2002-10-01 |
| Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer (NCT00033137) | National Cancer Institute (NCI) | 2002-05-13 |
| A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma (NCT00059735) | Eisai Inc. | 2002-05-01 |
| EPO906 Therapy in Patients With Advanced Kidney Cancer (NCT00035243) | Novartis Pharmaceuticals | 2002-04-01 |
| Von Hippel-Lindau Disease Genetic Epidemiology Study (NCT00001803) | National Cancer Institute (NCI) | 1999-02-26 |
| Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors (NCT00001668) | National Institute of Neurological Disorders and Stroke (NINDS) | 1997-04-01 |
| A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer (NCT00001570) | National Cancer Institute (NCI) | 1997-02-01 |
| Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer (NCT00134186) | Pharmacyclics LLC. | |